Prime Medicine Inc.
PRME | NASDAQ
$3.19
+$0.07 (+2.24%)
At close: Sep 21, 2026, 4:00 PM ET
$3.22
+$0.03 (+0.94%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -42.11M | -49.12M | -46.08M | -50.58M | -52.59M | -51.89M | -42.28M | -52.52M | -55.33M | -45.76M | -65.64M | -50.71M | -42.39M | -39.4M | -39.28M | -29.35M | -29.35M | -23.84M | -62.91M | -16.41M | 616K | -86.66M |
Depreciation & Amortization | 1.04M | 1.86M | 514K | 1.88M | 1.45M | 1.54M | 1.72M | 1.56M | 1.54M | 1.32M | 1.25M | 1.24M | 1.12M | 1.05M | 870K | 631K | 430K | 293K | 229K | 167K | 1.16M | 717K |
Stock-Based Compensation | 4.87M | 4.64M | 4.52M | 12.75M | 6.33M | 5.68M | 5.94M | 6.83M | 8.09M | 5.21M | 4.43M | 4.22M | 3.58M | 1.68M | 2.57M | 1.42M | 1.35M | 1.12M | 1.11M | 339K | n/a | n/a |
Other Working Capital | 6.05M | -6.05M | 1.74M | -2.55M | 4M | -9.52M | 46.4M | 2.06M | 12.1M | -24.23M | 12.17M | -3.36M | -7.19M | -8.11M | 740K | -3.45M | 185K | -35.34M | 31.48M | -905K | -707K | 122K |
Other Non-Cash Items | -7.34M | 2.41M | 2.64M | 306K | 2.85M | 3.47M | 2M | 14.65M | -8.41M | 1.51M | 6.3M | 3.8M | 2.42M | 3.92M | 4.16M | 840K | 6.23M | 6.45M | 15.58M | 9.45M | -9.55M | 81.53M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -134K | 134K | -4.64M | -108K | 31K | -202K | -202K | 212K | -442K | -532K | 1.24M | -2.37M | 1.12M | -615K |
Change in Working Capital | -466K | -2.5M | 1.16M | 609K | 548K | -7.65M | 48.86M | 3.58M | 8.75M | -30.11M | 14.45M | 2.4M | -5.59M | -8.62M | 1.17M | -3.85M | 1.57M | -34.29M | 31.56M | -780K | 240K | 155K |
Operating Cash Flow | -44.01M | -42.71M | -37.26M | -35.04M | -41.41M | -48.86M | 16.25M | -25.91M | -45.49M | -67.71M | -43.86M | -39.17M | -40.82M | -41.56M | -30.71M | -30.1M | -20.22M | -50.79M | -13.19M | -9.61M | -6.41M | -4.88M |
Capital Expenditures | -46K | -214K | -290K | -247K | -1.57M | -2.42M | -1.79M | -1.28M | -1.9M | -2.32M | -1.84M | -2.91M | -1.98M | -2M | -4.81M | -4.79M | -4.8M | -1.69M | -382K | -1.82M | -926K | -1.02M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -43.13K | 34.86K | n/a | n/a | n/a | 8.72K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -18.99M | -7.28M | -15.88M | -134.31M | -6.91M | -48.32M | 16.87M | -10.41M | -28.7M | -107.21M | -4.41M | -54.88M | 7K | -45.67M | -33.87M | -14.72M | -74.74M | n/a | -139K | -5.92M | -75.92M | n/a |
Sales Maturities Of Investments | 43.07M | 50.89M | 44.5M | 42.43M | 11.25M | 3M | 32.9M | 61.3M | 37.5M | 72.5M | 47.54M | 20.02M | 30M | 35M | 25M | 6M | 29.5M | 32.5M | 13M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 276K | 724K | n/a | n/a | 43.13K | -34.86K | -170K | n/a | -1K | -8.72K | -745K | 81K | -325K | 108K | -325K | 46K |
Investing Cash Flow | 24.03M | 43.39M | 28.33M | -92.12M | 2.77M | -47.74M | 48.25M | 50.34M | 6.89M | -37.03M | 41.29M | -37.77M | 27.86M | -12.67M | -13.69M | -13.51M | -50.79M | 30.89M | 12.15M | -7.64M | -77.17M | -972K |
Debt Repayment | n/a | n/a | -6M | n/a | n/a | 6M | n/a | n/a | n/a | 6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 361K | n/a | 145.51M | 6M | n/a | n/a | n/a | 432K | -151.29M | 19.27M | n/a | n/a | n/a | n/a | -1.18M | -746K | -624K | -1.27M | -1.09M | n/a | n/a | n/a |
Financial Cash Flow | -32K | 393K | 562K | 144.75M | 197K | 6M | 1K | 38.51M | 35K | 157.33M | 194K | 318K | 75K | 68K | 184.07M | -683K | -624K | -1.27M | -1.09M | -1K | 268.05M | 2.31M |
Net Cash Flow | -20.01M | 1.07M | -8.36M | 17.59M | -38.44M | -90.6M | 64.5M | 62.94M | -38.56M | 52.59M | -2.39M | -76.62M | -12.88M | -54.16M | 139.67M | -44.29M | -71.64M | -21.17M | -2.12M | -17.24M | 184.47M | -3.54M |
Free Cash Flow | -44.06M | -42.92M | -37.55M | -35.29M | -42.98M | -51.28M | 14.45M | -27.19M | -47.39M | -70.03M | -45.7M | -42.08M | -42.8M | -43.56M | -35.53M | -34.89M | -25.03M | -52.48M | -13.57M | -11.43M | -7.34M | -5.9M |
Adj. Free Cash Flow | -48.92M | -47.57M | -42.06M | -48.03M | -49.31M | -56.96M | 8.51M | -34.02M | -55.48M | -75.24M | -50.13M | -46.29M | -46.38M | -45.24M | -38.1M | -36.31M | -26.37M | -53.6M | -14.68M | -11.77M | -7.34M | -5.9M |
Maintenance CapEx | -46K | -214K | -290K | n/a | n/a | n/a | n/a | n/a | -1.9M | n/a | -1.84M | -2.91M | -1.98M | -2M | -4.81M | -4.79M | -4.8M | -1.69M | -382K | -1.82M | -926K | -1.02M |
Growth CapEx | n/a | n/a | n/a | -247K | -1.57M | -2.42M | -1.79M | -1.28M | n/a | -2.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -44.06M | -42.92M | -37.55M | -35.04M | -41.41M | -48.86M | 16.25M | -25.91M | -47.39M | -67.71M | -45.7M | -42.08M | -42.8M | -43.56M | -35.53M | -34.89M | -25.03M | -52.48M | -13.57M | -11.43M | -7.34M | -5.9M |
Add to Watchlist
Select watchlists to add or remove PRME